Abstract
Amyloidosis is a group of infiltrative diseases based on abnormal fibrillogenesis, i.e. the ability of some proteins - amyloid precursors, under certain conditions, to form insoluble thread-like structures - fibrils. Modern classifications of amyloidosis are based on the principle of specificity of the main fibrillogen protein - the amyloid precursor. Systemic forms of amyloidosis mainly include diseases involving blood plasma proteins. Certain types of amyloidosis tend to affect certain target organs. The prognosis of the disease largely depends on which organ is most severely affected. In systemic senile amyloidosis, the cardiovascular system is predominantly affected. Serum amyloid A (AA type) is an acute-phase protein synthesized in the liver. The cardiovascular system is affected relatively rarely in systemic AA amyloidosis, in approximately 0.1-10% of cases.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Spravočnik vrača obŝej praktiki (Journal of Family Medicine)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
